Ethicon Inc.

Optinose Announces CEO Transition and Business Update

Retrieved on: 
Tuesday, January 31, 2023
GAAP, Diagnosis, ENT, Ear, Military reserve force, Lieutenant colonel, Walter Reed Army Institute of Research, Medication, Nose, Ethicon Inc., Drug discovery, MPH, Policy, New Drug Application, Polyp (medicine), Patient, University, Army of the United States, FDA, Health, OPTN, Africa/Harvard School of Public Health Partnership for Cohort Research and Training, Growth, Sinusitis, Johnson & Johnson, Services General Administration and Coordination Department, Government of Sindh, Textbook, Research, Public health, Management, Pharmaceutical industry, Medical device, MD

In announcing his departure, Peter Miller shared, "It has been a privilege working with the amazing group of colleagues at Optinose.

Key Points: 
  • In announcing his departure, Peter Miller shared, "It has been a privilege working with the amazing group of colleagues at Optinose.
  • During Mr. Miller’s nearly 13 years as CEO, the Company experienced significant growth.
  • Dr. Mahmoud, the Company’s President and Chief Operating Officer since 2010, will succeed Mr. Miller as the new CEO of Optinose and as a Board member, effective immediately.
  • “Ramy’s leadership and accomplishments, deep industry experience, and medical background make him ideally suited to succeed Peter as CEO of Optinose,” said Joseph C. Scodari, Chairman of the Optinose Board of Directors.

Canada Laparoscopy Devices Market Report 2022: Analysis and Forecasts 2021-2031 - Rising Regulatory Approvals for Robotic Systems - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 22, 2022
Surgery, Health, Medical Devices, Medtronic, Health Canada, Scholly, COVID-19, Risk, Johnson & Johnson, Acquisition, Growth, Benchmarking, Intuitive Surgical, Laparoscopy, Ethicon Inc., Robotics, General surgery, Hugo, Medical device, Animal, Pharmaceutical industry, Dentistry

The "Canada Laparoscopy Devices Market: Focus on Product, Application, and End User - Analysis and Forecast, 2022-2031" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Canada Laparoscopy Devices Market: Focus on Product, Application, and End User - Analysis and Forecast, 2022-2031" report has been added to ResearchAndMarkets.com's offering.
  • The COVID-19 pandemic has impacted practically all sectors and social functions worldwide, including the Canada laparoscopy devices market.
  • COVID-19 led to a decline in the Canada laparoscopy devices market, as elective and surgical procedures were stopped during the lockdown.
  • The conventional laparoscopy devices segment holds the larger share in the Canada laparoscopy devices market at $350.6 million compared to the robotic-assisted laparoscopy devices segment which is valued at $41.5 million in the year 2021.

Surgical Sealants, Adhesives and Hemostats Global Market - Forecast to 2029

Retrieved on: 
Thursday, December 22, 2022
Merck KGaA v. Integra Lifesciences I, Ltd., Johnson & Johnson, General surgery, Gel, SAH, Adhesive, Ethicon Inc., Baxter International, Medtronic, Bleeding, Urology, Hospital, Health, Ageing, Infection, Geography, Fibrin, Speciality chemicals, Hemostasis, Orthopedic surgery, Pulmonology, Others, Gynaecology, Teleflex, CryoLife, Neurosurgery

View original content:https://www.prnewswire.com/news-releases/surgical-sealants-adhesives-and...

Key Points: 
  • According to IQ4I analysis, the SAH global market is expected to grow at mid-single digit CAGR from 2022 to 2029 to reach $4,366.0 million by 2029.
  • The SAH global market is mainly segmented based on products, applications, end-users, and based on geography.
  • Among these, the hemostat accounted for the largest revenue in 2022 and is expected to grow at mid-single digit CAGR from 2022 to 2029.
  • Hemostats are classified based on function into mechanical hemostats, active hemostats, flowable hemostats, and fibrin sealants hemostats, among them, the mechanical hemostats accounted for the largest revenue in 2022 and are expected to grow at mid-single digit CAGR from 2022 to 2029.

Medical Engineered Materials Global Market Report 2022: Ukraine-Russia War Impact

Retrieved on: 
Monday, December 12, 2022
BASF SE, DuPont Experimental Station, Ethicon Inc., SE, Conditional sentence, Myocardial infarction, CVD, Trelleborg (company), Plastic, Carbon footprint, Degenerative disease, Stroke, N, SABIC, Prevalence, Science, LCA, SABIC (Saudia), DuPont, Medicine, World Health Organization, Evonik Industries, Celanese, COVID-19, Death, Growth, WHO, BASF, Organization, Acquisition, Medical device, Pharmaceutical industry, Renewable energy

The medical engineered materials market consists of sales of medical engineered products by entities (organizations, sole traders, and partnerships) that are used to integrate key materials science modules with an understanding of medical design.Medical engineered materials refer to a material that is engineered to specific or custom requirements to engage with biological systems in a therapeutic or diagnostic manner for medical purposes.

Key Points: 
  • The medical engineered materials market consists of sales of medical engineered products by entities (organizations, sole traders, and partnerships) that are used to integrate key materials science modules with an understanding of medical design.Medical engineered materials refer to a material that is engineered to specific or custom requirements to engage with biological systems in a therapeutic or diagnostic manner for medical purposes.
  • The main types of medical engineered materials are medical plastics, medical foams, medical films, medical adhesives, and medical elastomers.Medical-grade plastic materials refer to plastics designed to make medical products.
  • The regions covered in this medical engineered materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
  • The medical engineered materials market research report is one of a series of new reports that provides medical engineered materials market statistics, including medical engineered materials industry global market size, regional shares, competitors with a medical engineered materials market share, detailed medical engineered materials market segments, market trends and opportunities, and any further data you may need to thrive in the medical engineered materials industry.

Medical Electrodes Global Market Report 2022: Ukraine-Russia War Impact

Retrieved on: 
Wednesday, November 30, 2022
COVID-19, Neurophysiology, Electrode, Diagnosis, Cardiology, EMG, Thermo Fisher Scientific, Electroencephalography, Medtronic, Electrocardiography, Organization, Electromyography, Ethicon Inc., GE Healthcare, Cardinal Health, Lead, Boston Scientific, Electricity, Percussion section, Sleep, 3M, Acquisition, Medical device, Electric battery

The main usability of medical electrodes is disposable medical electrodes and reusable medical electrodes.Disposable medical electrodes refer to the disposable medical electrode consisting of a disc made of a semi-rigid plastic substance with a centrally positioned recessed embossment.

Key Points: 
  • The main usability of medical electrodes is disposable medical electrodes and reusable medical electrodes.Disposable medical electrodes refer to the disposable medical electrode consisting of a disc made of a semi-rigid plastic substance with a centrally positioned recessed embossment.
  • The market is witnessing the demand for prominent electrodes such as electrocardiography electrodes, electroencephalography electrodes, and others.Major companies operating in the medical electrodes market are advancing new technologies and advanced medical electrodes products to strengthen their market position.
  • The market is witnessing the demand for prominent electrodes such as electrocardiography electrodes, electroencephalography electrodes, and others.Major companies operating in the medical electrodes market are advancing new technologies and advanced medical electrodes products to strengthen their market position.
  • The medical electrodes market research report is one of a series of new reports that provides medical electrodes market statistics, including medical electrodes industry global market size, regional shares, competitors with an medical electrodes market share, detailed medical electrodes market segments, market trends and opportunities, and any further data you may need to thrive in the medical electrodes industry.

Keurig Dr Pepper Announces Appointment of New Director to its Board

Retrieved on: 
Thursday, November 17, 2022
Well, Oral and maxillofacial surgery, Keurig Dr Pepper, Johnson & Johnson, Health, Keurig, Growth, Water, KDP, Marketing, Drink, Snapple, CORE, Tea, Animal Health, Ethicon Inc., Worldwide, Coffee, Pharmaceutical industry, Soft drink, Extremities, Trauma

and FRISCO, Texas, Nov. 17, 2022 /PRNewswire/ -- Keurig Dr Pepper (NASDAQ: KDP) today announced that Oray Boston, Worldwide President of Trauma, Extremities, Craniomaxillofacial and Animal Health at DePuy Synthes, the Orthopaedics Company of Johnson & Johnson, has been elected as a Director of the KDP Board, effective Nov. 14, 2022.

Key Points: 
  • and FRISCO, Texas, Nov. 17, 2022 /PRNewswire/ -- Keurig Dr Pepper (NASDAQ: KDP) today announced that Oray Boston, Worldwide President of Trauma, Extremities, Craniomaxillofacial and Animal Health at DePuy Synthes, the Orthopaedics Company of Johnson & Johnson, has been elected as a Director of the KDP Board, effective Nov. 14, 2022.
  • During his 30-year tenure at Johnson & Johnson that has included leadership positions in operations, sales and marketing, Boston led cross-functional and cross-sector teams that delivered commercial growth and differentiated innovation.
  • Prior roles held by Boston included President of Global Biosurgery, Vice President of Sales & Marketing and Worldwide Vice President of Franchise Operations at Ethicon, a Johnson & Johnson MedTech company.
  • Keurig Dr Pepper (KDP) is a leading beverage company in North America, with annual revenue approaching $13 billion and approximately 27,000 employees.

The Worldwide Colorectal Procedure Industry is Expected to Reach $29.5 Billion by 2028 - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 10, 2022
Health, Surgery, Oncology, Other Health, Prevalence, Amazon, Food, Risk, GI, Cade, Colorectal cancer, PAP, Google Images, Artificial intelligence, COVID-19, Bleeding, US Foods, ECHELON, Polyp (medicine), Safety, Large intestine, Colonoscopy, Endoscopy, Stoma, Clinical trial, Luer, IDA, Physician, Patient, Growth, Crohn's disease, Colorectal surgery, Blood, FDA, CAGR, Pharmaceutical industry, Medical device, Medicare, Medtronic, Ethicon Inc.

The global colorectal procedure market is projected to reach US$ 29,550.98 million by 2028 from US$ 12,496.49 million in 2021.

Key Points: 
  • The global colorectal procedure market is projected to reach US$ 29,550.98 million by 2028 from US$ 12,496.49 million in 2021.
  • It is expected to register a CAGR of 13.1% from 2021 to 2028.
  • The increasing prevalence of colorectal cancer and new product launches drive the growth of colorectal procedure.
  • The colorectal procedural market players focus on launching new products to expand their geographic reach and enhance capacities to cater to a large customer base.

UroGen Announces the Appointment of Dan Wildman to the UroGen Pharma Board of Directors

Retrieved on: 
Wednesday, November 9, 2022
Biotechnology, Other Health, Health, Pharmaceutical, Oncology, Marketing, Strategic planning, Hemostasis, Nasdaq, St. Lawrence University, Technology, Board, Solution, Board of directors, Johnson & Johnson, Company, Neoplasm, Patient, Mitomycins, Surgeon, Worldwide, Boston Scientific, Economics, Fine chemical, Pharmaceutical industry, Management, Medicine, Maggot therapy, Ethicon Inc.

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today announced the appointment of Dan Wildman to its Board of Directors, effective immediately.

Key Points: 
  • UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today announced the appointment of Dan Wildman to its Board of Directors, effective immediately.
  • Dan Wildman, Chairman of the Board of Progenerative Medical, Inc., a 40-year veteran of the medical device industry, and Strategic Advisor to several medical device and pharmaceutical companies, has agreed to join UroGens board, effective immediately.
  • We are pleased to welcome Dan Wildman to UroGens Board of Directors, said Liz Barrett, President and Chief Executive Officer, UroGen.
  • I am impressed with UroGens innovative technology and its potential to disrupt other areas of urologic oncology, said Dan Wildman.

Global Endometrial Ablation Devices Market Analysis Report 2022: A $990.9 Million Market in 2021 - Forecasts to 2028 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, November 1, 2022
Medical Devices, Health, Awareness, Endometrial ablation, Growth, Population, The Cooper Companies, Mergers and acquisitions, Olympus Corporation, Hospital, MEA, PCOD, Radiofrequency ablation, Uterus, Industry, COVID-19, SCSI Peripheral Device Type, Menstruation, Johnson & Johnson, Ethicon Inc., End user, Workforce, Incidence, Education, Investment, USD, Woman, Karl Storz SE, Medtronic, Prevalence, Mergers & Acquisitions, Lithium, Birth control, Retail, Hysterectomy

The Global Endometrial Ablation Devices Market was valued at USD 990.9 Million in the year 2021 with the Americas region leading the regional market share.

Key Points: 
  • The Global Endometrial Ablation Devices Market was valued at USD 990.9 Million in the year 2021 with the Americas region leading the regional market share.
  • The Asia Pacific Endometrial Ablation Devices market is predicted to be the hotspot and the most lucrative region for market participants worldwide.
  • The report analyses the Endometrial Ablation Devices Market by Device Type (Radiofrequency Ablators, Thermal balloon Ablators, Cryoablation Devices, Hydrothermal Ablators, Electrical Ablators and Others).
  • The Global Endometrial Ablation Devices Market has been analysed By Region (Americas, Europe, Asia Pacific, and MEA).

Insights on the Flowable Hemostats Global Market to 2028 - Featuring Baxter International, Teleflex and Pfizer Among Others - ResearchAndMarkets.com

Retrieved on: 
Monday, September 26, 2022
Health, Medical Supplies, Medical Devices, Injury, Adoption, BMJ (company), Traumatic brain injury, Lists of diseases, COVID-19, Risk, Research, BioMed Central, Thrombin, Hydrolysis, Patient, Disease, United States National Library of Medicine, Public health, Sport, TBI, Collagen, R, Brain, Hospital, Mortality, Skin, Calcium chloride, National library, Gelatin, CAGR, Pharmaceutical industry, Health insurance, EU, Ethicon Inc.

The "Flowable Hemostats Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Material, Product, Application, and End-user" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Flowable Hemostats Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Material, Product, Application, and End-user" report has been added to ResearchAndMarkets.com's offering.
  • The flowable hemostats market is projected to reach US$ 458.9 million by 2028 from US$ 304.9 million in 2022.
  • Research and development (R&D) activities coupled with product innovations act as a future trend in the flowable hemostats market.
  • The flowable hemostats market is segmented into Europe, China, and Japan.